RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome

A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome

Add to Collection
RCTs NL Klupp, H Kiat, A Bensoussan, GZ Steiner… - Scientific reports, 2016 - nature.com

Chapter : Section9
Journal Year : 2016
Cited by : 62

… risk factors among individuals with type 2 diabetes mellitus and metabolic syndrome. As the anticipated sample size was not reached, and the two interventions groups contained the …..... Read More

Keywords : ['doubleblind randomise placebocontrolle trial', 'cardiovascular risk factor', 'metabolic syndrome', 'ganoderma lucidum', 'treatment']
PubMed Link : https://www.nature.com/articles/srep29540
Google Scholar Link : https://scholar.google.com/scholar?cites=2348885120181842657&as_sdt=2005&sciodt=0,5&hl=en&num=20